Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1531 AL 1545

The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial

Kehoe PG, Blair PS, Howden B, Thomas DL, Malone IB, Horwood J, Clement C, Selman LE, Baber H, Lane A, Coulthard E, Passmore AP, Fox NC, Wilkinson IB, Ben-Shlomo Y.

J Alzheimers Dis. 2018;61(2):803-814. doi: 10.3233/JAD-170101.

While I Still Remember: 30 Years of Alzheimer's Disease Research

Shea TB.

J Alzheimers Dis. 2018;62(3):1049-1057. doi: 10.3233/JAD-170724.

Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development

Wischik CM, Schelter BO, Wischik DJ, Storey JMD, Harrington CR.

J Alzheimers Dis. 2018;62(3):1287-1303. doi: 10.3233/JAD-170727.

Nicotinamide adenine dinucleotide and its related precursors for the treatment of Alzheimer's disease

Braidy N, Grant R, Sachdev PS.

Curr Opin Psychiatry. 2018 Mar;31(2):160-166. doi: 10.1097/YCO.0000000000000394.

Nanomedicine Strategies for Sustained, Controlled and Targeted Treatment of Alzheimer's Disease

Ma TJ, Gao J, Liu Y, Zhuang JH, Yin C, Li P, Mao L, Xu J, Xu YX, Li YP, Zhao ZX, Yin Y.

Mini Rev Med Chem. 2018;18(12):1035-1046. doi: 10.2174/1389557518666171215150024.

Toward a Rational Design to Regulate β-Amyloid Fibrillation for Alzheimer's Disease Treatment

Han X, He G.

ACS Chem Neurosci. 2018 Feb 21;9(2):198-210. doi: 10.1021/acschemneuro.7b00477. Epub 2018 Jan 3.

Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial

Wharton W, Goldstein FC, Tansey MG, Brown AL, Tharwani SD, Verble DD, Cintron A, Kehoe PG.

J Alzheimers Dis. 2018;61(2):815-824. doi: 10.3233/JAD-161198.

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications

Folch J, Busquets O, Ettcheto M, Sánchez-López E, Castro-Torres RD, Verdaguer E, Garcia ML, Olloquequi J, Casadesús G, Beas-Zarate C, Pelegri C, Vilaplana J, Auladell C, Camins A.

J Alzheimers Dis. 2018;62(3):1223-1240. doi: 10.3233/JAD-170672.

Nutrition: Review on the Possible Treatment for Alzheimer's Disease

Botchway BOA, Moore MK, Akinleye FO, Iyer IC, Fang M.

J Alzheimers Dis. 2018;61(3):867-883. doi: 10.3233/JAD-170874.

Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake

Sanz-Blasco S, Calvo-Rodriguez M, Caballero E, Garcia-Durillo M, Nunez L, Villalobos C.

Curr Alzheimer Res. 2018;15(6):504-510. doi: 10.2174/1567205015666171227154016.

[Alzheimer's disease - State of the art, and emerging diagnostics and therapeutics]

Winkler D, Leyhe T.

Ther Umsch. 2018;75(7):432-437. doi: 10.1024/0040-5930/a001020.

Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer's disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice

Che H , Zhou M , Zhang T , Zhang L , Ding L , Yanagita T , Xu J , Xue C , Wang Y .

Food Funct. 2018 Jan 24;9(1):643-654. doi: 10.1039/c7fo01342f.

Biophysical interaction of resveratrol with sirtuin pathway: Significance in Alzheimer's disease

Mohan S, Gobinath T, Salomy A, Nisha M, Kandasamy M, Essa MM, Jayachandran KS, Anusuyadevi M.

Front Biosci (Landmark Ed). 2018 Mar 1;23(7):1380-1390. doi: 10.2741/4650.

Long-Lasting Neuropsychological Effects of a Computerized Cognitive Training in Patients Affected by Early Stage Alzheimer's Disease: Are They Stable Over Time?

Cavallo M, Angilletta C.

J Appl Gerontol. 2019 Jul;38(7):1035-1044. doi: 10.1177/0733464817750276. Epub 2018 Jan 2.

Medicinal plants with acetylcholinesterase inhibitory activity

Patel SS, Raghuwanshi R, Masood M, Acharya A, Jain SK.

Rev Neurosci. 2018 Jul 26;29(5):491-529. doi: 10.1515/revneuro-2017-0054.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias